About 1 in 4 American adults got a covid vaccine shot during the 2024-25 virus season, a fraction health care experts warn could be smaller this year as millions wrestle with conflicting advice from ...

"This is very exciting," says one infectious disease doctor. The new RSV vaccines were approved in 2023—and today’s research ...

After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV -- and more are on the way. On Wednesday, the US Food and Drug Administration ...

ATLANTA — Moderna’s respiratory syncytial virus vaccine is safe and effective for adults who have received a solid organ ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

Anxiety is high among parents as more kids head back to school without the protection of a COVID-19 vaccine for at least a few more months. Parents have a reason to be concerned. After months of ...

Through his leadership at the FDA's Center for Biologics Evaluation and Research (CBER), Vinay Prasad, MD, MPH has pushed out at least 7 senior leaders and created an environment that employees worry ...

Vaccine manufacturing is challenged by stringent global regulations, essential for ensuring safety and efficacy, with ...

Natasha Smith has seen her views on vaccines transform. “I had been reading books about pregnancy and parenthood of toddlers, ...

An alleged extortion attempt, a petty yearslong grudge, shocking social media posts, and ominous text messages make up the ...